In vitro antiviral activity of Lactobacillus casei and Bifidobacterium adolescentis against rotavirus infection monitored by NSP4 protein production

Journal of Applied Microbiology

Volumn 120, Issue 4, 2016, Pages 1041-1051

  Olaya Galan N N ^a   Ulloa Rubiano, J C ^a   Velez Reyes, F A ^b   Fernandez Duarte, K P ^a   Salas Cardenas S P ^a   Gutierrez Fernandez, M F ^a  

^a PONTIFICIA UNIVERSIDAD JAVERIANA   (Colombia)

^b UNIVERSIDAD EL BOSQUE   (Colombia)

Author keywords

Antiviral effect; Bifidobacterium adolescentis; Lactobacillus casei; NSP4 protein; Probiotic metabolites; Rotavirus

Indexed keywords

BIOMOLECULES; ELECTROLYTES; METABOLITES;

ANTI-VIRAL EFFECTS; ANTIVIRAL ACTIVITIES; BIFIDOBACTERIUM ADOLESCENTIS; CA 2+; IN-VITRO; LACTOBACILLUS CASEI; NSP4 PROTEIN; PROBIOTIC METABOLITE; PROBIOTICS; ROTAVIRUSES;

PROTEINS;

CALCIUM; ELECTROLYTE; PROBIOTIC AGENT; ROTAVIRUS NONSTRUCTURAL PROTEIN 4; ANTIVIRUS AGENT; GLYCOPROTEIN; NS28 PROTEIN, ROTAVIRUS; TOXIN; VIRAL PROTEIN;

ANTIMICROBIAL ACTIVITY; BACTERIUM; CALCIUM; CELLS AND CELL COMPONENTS; ELECTROLYTE; FLOW CYTOMETRY; METABOLITE; PROBIOTICS; PROTEIN; VIRAL DISEASE;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; BIFIDOBACTERIUM ADOLESCENTIS; BIFIDOBACTERIUM BIFIDUM; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CONTROLLED STUDY; FLOW CYTOMETRY; IN VITRO STUDY; LACTOBACILLUS CASEI; LACTOBACILLUS FERMENTUM; METABOLITE; NONHUMAN; RHESUS MONKEY; ROTAVIRUS INFECTION; ANIMAL; CELL LINE; DRUG EFFECTS; METABOLISM; ROTAVIRUS; ROTAVIRUS INFECTIONS; VIROLOGY;

BIFIDOBACTERIUM ADOLESCENTIS; LACTOBACILLUS; LACTOBACILLUS CASEI; ROTAVIRUS;

ANIMALS; ANTIVIRAL AGENTS; BIFIDOBACTERIUM ADOLESCENTIS; CELL LINE; GLYCOPROTEINS; LACTOBACILLUS CASEI; MACACA MULATTA; PROBIOTICS; ROTAVIRUS; ROTAVIRUS INFECTIONS; TOXINS, BIOLOGICAL; VIRAL NONSTRUCTURAL PROTEINS;

EID: 84962599392     PISSN: 13645072     EISSN: 13652672     Source Type: Journal    
DOI: 10.1111/jam.13069     Document Type: Article

References (53)

1. An, H.M., Lee, D.K., Kim, J.R., Lee, S.W., Cha, M.K., Lee, K.O. and Ha, N.J. (2012) Antiviral activity of Bifidobacterium adolescentis SPM 0214 against herpes simplex virus type 1. Arch Pharm Res 35, 1665-1671.
2. Ball, J.M., Mitchell, D.M., Gibbons, T.F. and Parr, R.D. (2005) Review rotavirus NSP4: a multifunctional viral enterotoxin. Viral Immunol 18, 27-40.
3. Bermudez-Brito, M., Plaza-Díaz, J., Muñoz-Quezada, S., Gómez-Llorente, C. and Gil, A. (2012) Probiotic mechanisms of action. Ann Nutr Metab 61, 160-174.
4. Binns, C. and Lee, M.K. (2010) The use of probiotics to prevent diarrhea in young children attending child care centers: a review. J Exp Clin Med 2, 269-273.
5. Borthakur, A., Gill, R.K., Tyagi, S., Koutsouris, A., Alrefai, W.A., Hecht, G.A., Ramaswamy, A. and Dudeja, P.K. (2008) The probiotic Lactobacillus acidophilus stimulates chloride/hydroxyl exchange activity in human intestinal epithelial cells. J Nutr 138, 1355-1359.
6. Botić, T., Klingberg, T.D., Weingartl, H. and Cencic, A. (2007) A novel eukaryotic cell culture model to study antiviral activity of potential probiotic bacteria. Int J Food Microbiol 115, 227-234.
7. Cha, M.-K., Lee, D.-K., An, H.-M., Lee, S.-W., Shin, S.-H., Kwon, J.H., Kim, K.J. and Ha, N.J. (2012) Antiviral activity of Bifidobacterium adolescentis SPM1005-A on human papillomavirus type 16. BMC Med 10, 72.
8. Chai, W., Burwinkel, M., Wang, Z., Palissa, C., Esch, B., Twardziok, S., Rieger, J., Wrede, P. et al. (2013) Antiviral effects of a probiotic Enterococcus faecium strain against transmissible gastroenteritis coronavirus. Arch Virol 158, 799-807.
9. Chapman, C.M.C., Gibson, G.R. and Rowland, I. (2012) In vitro evaluation of single- and multi-strain probiotics: inter-species inhibition between probiotic strains, and inhibition of pathogens. Anaerobe 18, 405-413.
10. Colbère-Garapin, F., Martin-Latil, S., Blondel, B., Mousson, L., Pelletier, I., Autret, A., Francois, A., Niborski, V. et al. (2007) Prevention and treatment of enteric viral infections: possible benefits of probiotic bacteria. Microbes Infect 9, 1623-1631.
11. Dennehy, P.H. (2013) Treatment and prevention of rotavirus infection in children. Curr Infect Dis Rep 15, 242-250.
12. Díaz, Y., Chemello, M.E., Peña, F., Aristimuño, O.C., Zambrano, J.L., Rojas, H., Bartoli, F., Salazar, L. et al. (2008) Expression of nonstructural rotavirus protein NSP4 mimics Ca2 + homeostasis changes induced by rotavirus infection in cultured cells. J Virol 82, 11331-11343.
13. Didsbury, A., Wang, C., Verdon, D., Sewell, M.A., McIntosh, J.D. and Taylor, J.A. (2011) Rotavirus NSP4 is secreted from infected cells as an oligomeric lipoprotein and binds to glycosaminoglycans on the surface of non-infected cells. Virol J 8, 551.
14. Dong, Y., Zeng, C.Q., Ball, J.M., Estes, M.K. and Morris, A.P. (1997) The rotavirus enterotoxin NSP4 mobilizes intracellular calcium in human intestinal cells by stimulating phospholipase C-mediated inositol 1, 4, 5-trisphosphate production. Proc Natl Acad Sci USA, 94, 3960-3965.
15. Erdoğan, O., Tanyeri, B., Torun, E., Gönüllü, E., Arslan, H., Erenberk, U. and Öktem, F. (2012) The comparition of the efficacy of two different probiotics in rotavirus gastroenteritis in children. J Trop Med 2012, 787240.
16. Grandy, G., Medina, M., Soria, R., Terán, C.G. and Araya, M. (2010) Probiotics in the treatment of acute rotavirus diarrhoea. A randomized, double-blind, controlled trial using two different probiotic preparations in Bolivian children. BMC Infect Dis 10, 253.
17. Greenberg, H.B. and Estes, M.K. (2009) Rotavirus: from pathogenesis to vaccination. Gastroenterology 136, 1939-1951.
18. Guandalini, S. (2011) Probiotics for prevention and treatment of diarrhea. J Clin Gastroenterol, 45(Suppl), S149-S153.
19. Hyser, J.M., Zeng, C.Q.-Y., Beharry, Z., Palzkill, T. and Estes, M.K. (2008) Epitope mapping and use of epitope-specific antisera to characterize the VP5 binding site in rotavirus SA11 NSP4. Virology 373, 211-228.
20. Katre, N.V. (1993) The conjugation of proteins with polyethylene glycol and other polymers. Adv Drug Deliv Rev 10, 91-114.
21. Kim, M.J., Lee, D.K., Park, J.E., Park, I.H., Seo, J.G. and Ha, N.J. (2014) Antiviral activity of Bifidobacterium adolescentis SPM1605 against Coxsackievirus B3. Biotechnol Biotechnol Equip 28, 681-688.
22. Kopp-Hoolihan, L. (2001) Prophylactic and therapeutic uses of probiotics: a review. J Am Diet Assoc 101, 229-241.
23. Lee, D.K., Kang, J.Y., Shin, H.S., Park, I.H. and Ha, N.J. (2013a) Antiviral activity of Bifidobacterium adolescentis SPM0212 against Hepatitis B virus. Arch Pharm Res 36, 1525-1532.
24. Lee, I.-C., Tomita, S., Kleerebezem, M. and Bron, P.A. (2013b) The quest for probiotic effector molecules - unraveling strain specificity at the molecular level. Pharmacol Res, 69, 61-74.
25. Lee, D.K., Park, J.E., Kim, M.J., Seo, J.G., Lee, J.H. and Na, N.J. (2015) Probiotic bacteria, B. longum and L. acidophilus inhibit infection by rotavirus in vitro and decrease the duration of diarrhea in pediatric patients. Clin Res Hepatol Gastroenterol, 39, 237-244.
26. Liévin-Le Moal, V. and Servin, A.L. (2014) Anti-infective activities of lactobacillus strains in the human intestinal microbiota: from probiotics to gastrointestinal anti-infectious biotherapeutic agents. Clin Microbiol Rev 27, 167-199.
27. López, T., Camacho, M., Zayas, M., Nájera, R., Sánchez, R., Arias, C.F. and López, S. (2005) Silencing the morphogenesis of rotavirus. J Virol 79, 184-192.
28. Maragkoudakis, P.A., Chingwaru, W., Gradisnik, L., Tsakalidou, E. and Cencic, A. (2010) Lactic acid bacteria efficiently protect human and animal intestinal epithelial and immune cells from enteric virus infection. Int J Food Microbiol, 141(Suppl), S91-S97.
29. Mizock, B.A. (2015) Probiotics. Dis Mon 61, 259-290.
30. Muñoz, J.A.M., Chenoll, E., Casinos, B., Bataller, E., Ramón, D., Genovés, S., Montava, R., Ribes, J.M. et al. (2011) Novel probiotic Bifidobacterium longum subsp. infantis CECT 7210 strain active against rotavirus infections. Appl Environ Microbiol 77, 8775-8783.
31. Oelschlaeger, T.A. (2010) Mechanisms of probiotic actions - a review. Int J Med Microbiol, 300, 57-62.
32. Pachon del Amo, I., Martinez Aragon, M.V., Suarez, B., Sánchez Fauquier, A., Salmerón, F., Soler Soneira, M. and deJosé Gomez, M.I. (2006). Situación Epidemiológica de las Gastroenteritis Producidas por Rotavirus. Ponencia de Programa y Registro de Vacunaciones, Junio 2006. Madrid, España: Ministerio de Sanidad, Servicios Sociales e Igualdad.
33. Pando, V., Isa, P., Arias, C.F. and López, S. (2002) Influence of calcium on the early steps of rotavirus infection. Virology 295, 190-200.
34. Pant, N., Marcotte, H., Brüssow, H., Svensson, L. and Hammarström, L. (2007) Effective prophylaxis against rotavirus diarrhea using a combination of Lactobacillus rhamnosus GG and antibodies. BMC Microbiol 7, 86.
35. Papadimitriou, K., Zoumpopoulou, G., Foligné, B., Alexandraki, V., Kazou, M., Pot, B. and Tsakalidou, E. (2015) Discovering probiotic microorganisms: in vitro, in vivo, genetic and omics approaches. Front Microbiol 6, 58.
36. Raheja, G., Singh, V., Ma, K., Boumendjel, R., Borthakur, A., Saksena, S., Alrefai, W.A., Ramaswamy, K. et al. (2010) Lactobacillus acidophilus stimulates the expression of SLC26A3 via a transcriptional mechanism. Am J Physiol Gastrointest Liver Physiol 298, G395-G401.
37. Rodríguez-Díaz, J. and Monedero, V. (2013) Probiotics against digestive tract viral infections. In Bioactive Food as Dietary Interventions for Liver and Gastrointestinal Disease ed. Watson, R.R. and Preedy, V.R. pp. 271-284. San Diego: Elsevier.
38. Russell, D.A., Ross, R.P., Fitzgerald, G.F. and Stanton, C. (2011) Metabolic activities and probiotic potential of bifidobacteria. Int J Food Microbiol 149, 88-105.
39. Saad, N., Delattre, C., Urdaci, M., Schmitter, J.M.M. and Bressollier, P. (2013) An overview of the last advances in probiotic and prebiotic field. LWT - Food Sci Technol 50, 1-16.
40. Salminen, S., Nybom, S., Meriluoto, J., Collado, M.C., Vesterlund, S. and El-Nezami, H. (2010) Interaction of probiotics and pathogens - benefits to human health? Curr Opin Biotechnol 21, 157-167.
41. Tate, J.E., Burton, A.H., Boschi-Pinto, C., Steele, A.D., Duque, J., Parashar, U.D. and WHO-coordinated Global Rotavirus Surveillance Network. (2012) 2008 estimate of worldwide rotavirus-associated mortality in children younger than 5 years before the introduction of universal rotavirus vaccination programmes: a systematic review and meta-analysis. Lancet Infect Dis 12, 136-141.
42. Thomas, D.W. and Greer, F.R. (2010) Probiotics and prebiotics in pediatrics. Pediatrics 126, 1217-1231.
43. Tian, P., Hu, Y., Schilling, W.P., Lindsay, D.A., Eiden, J. and Estes, M.K. (1994) The nonstructural glycoprotein of rotavirus affects intracellular calcium levels. J Virol 68, 251-257.
44. Torres, N.I., Noll, K.S., Xu, S., Li, J., Huang, Q., Sinko, P.J., Wachsman, M.B. and Chikindas, M.L. (2013) Safety, formulation, and in vitro antiviral activity of the antimicrobial peptide subtilosin against herpes simplex virus type 1. Probiotics Antimicrob Proteins 5, 26-35.
45. Trask, S.D., McDonald, S.M. and Patton, J.T. (2012) Structural insights into the coupling of virion assembly and rotavirus replication. Nat Rev Microbiol 10, 165-177.
46. Treiman, M., Caspersen, C. and Christensen, S.B. (1998) A tool coming of age: thapsigargin as an inhibitor of sarco-endoplasmic reticulum Ca(2+)-ATPases. Trends Pharmacol Sci 19, 131-135.
47. Varyukhina, S., Freitas, M., Bardin, S., Robillard, E., Tavan, E., Sapin, C., Grill, J.P. and Trugnan, G. (2012) Glycan-modifying bacteria-derived soluble factors from Bacteroides thetaiotaomicron and Lactobacillus casei inhibit rotavirus infection in human intestinal cells. Microbes Infect 14, 273-278.
48. Ventola, H., Lehtoranta, L., Madetoja, M., Simonen-Tikka, M.-L., Maunula, L., Roivainen, M., Korpela, R. and Holma, R. (2012) Effects of the viability of Lactobacillus rhamnosus GG on rotavirus infection in neonatal rats. World J Gastroenterol 18, 5925-5931.
49. Yang, W. and McCrae, M.A. (2012) The molecular biology of rotaviruses X: intercellular dissemination of rotavirus NSP4 requires glycosylation and is mediated by direct cell-cell contact through cytoplasmic extrusions. Arch Virol, 157, 305-314.
50. Yen, C., Tate, J.E., Hyde, T.B., Cortese, M.M., Lopman, B.A., Jiang, B., Glass, R.I. and Parashar, U.D. (2014) Rotavirus vaccines: current status and future considerations. Hum Vaccin Immunother 10, 1436-1448.
51. Zabihollahi, R., Motevaseli, E., Sadat, S.M., Azizi-Saraji, A.R., Asaadi-Dalaie, S. and Modarressi, M.H. (2012) Inhibition of HIV and HSV infection by vaginal lactobacilli in vitro and in vivo. Daru 20, 53.
52. Zalipsky, S. (1995) Chemistry of polyethylene glycol conjugates with biologically active molecules. Adv Drug Deliv Rev 16, 157-182.
53. Zambrano, J.L., Díaz, Y., Peña, F., Vizzi, E., Ruiz, M.-C., Michelangeli, F., Liprandi, F. and Ludert, J.E. (2008) Silencing of rotavirus NSP4 or VP7 expression reduces alterations in Ca2+ homeostasis induced by infection of cultured cells. J Virol 82, 5815-5824.